Pasithea Therapeutics Corp. (KTTAW) EBT Margin (2022)

Pasithea Therapeutics has disclosed EBT Margin across 1 years of filings, most recently posting 2126.06% for Q4 2022.

• In Q4 2022, EBT Margin changed N/A year-over-year to 2126.06%; the TTM figure through Dec 2022 stood at 2864.29% (changed N/A YoY), while the FY2022 annual figure was 2864.29%, up 1156621.0% from the prior year.
• EBT Margin came in at 2126.06% for Q4 2022 at Pasithea Therapeutics, down from 2097.88% in the prior quarter.
• In the past five years, EBT Margin ranged from a high of 2097.88% in Q3 2022 to a low of 19574.36% in Q2 2022.